Stocks › GDRX

GoodRx Holdings, Inc.

GDRX·Nasdaq·United States United States·USD
$2.92
-0.10 (-3.31%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
GDRX
GoodRx Holdings, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GDRXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of GDRX by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Anthony E. GonzalezAnthony E. GonzalezHouse · R · OH GDRXGoodRx Holdings, Inc. · Stock Purchase
$100,001 - $250,000
Apr 23, 2021 Mar 25, 2021 Filing ↗

Whale Activity

Position changes in GDRX reported for 2026-09-30 by 195 institutional filers
Increased: 36New: 34Held: 42Decreased: 64Closed: 13No prior filing: 6
  • Increased36
  • New34
  • Held42
  • Decreased64
  • Closed13
  • No prior filing6

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by GDRX insiders, by quarter · Form 4
-5.0M-2.5M02.5M5.0M2025 Q1: 02025 Q12025 Q2: -10.7K2025 Q22025 Q3: -26.7K2025 Q32025 Q4: -23.8K2025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: -2.8M2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

738 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Chan Thomas (TC)Chief Accounting Officer Tax withholding −1,069 $3.56 $4K Sep 15, 2026 Form 4 ↗
Chan Thomas (TC)Chief Accounting Officer Option exercise +2,101 — — Sep 15, 2026 Form 4 ↗
Fengler JustinSee Remarks Tax withholding −330 $3.56 $1K Sep 15, 2026 Form 4 ↗
Fengler JustinSee Remarks Option exercise +752 — — Sep 15, 2026 Form 4 ↗
Fengler JustinSee Remarks Tax withholding −1,024 $3.56 $4K Sep 15, 2026 Form 4 ↗
Fengler JustinSee Remarks Option exercise +2,335 — — Sep 15, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −433.1K $3.50 $1.5M Aug 26, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −439.3K $3.50 $1.5M Aug 26, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −210.4K $3.51 $738K Aug 26, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −213.4K $3.51 $749K Aug 26, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −63.2K $3.44 $217K Aug 25, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −64.1K $3.44 $220K Aug 25, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −71.3K $3.46 $247K Aug 24, 2026 Form 4 ↗
FRANCISCO PARTNERS IV-A, L.P.10% owner Sale −72.3K $3.46 $250K Aug 24, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −136.4K $3.50 $477K Aug 21, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −138.3K $3.50 $484K Aug 21, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −213.8K $3.52 $753K Aug 20, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −233.4K $3.52 $822K Aug 20, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −234.3K $3.53 $827K Aug 19, 2026 Form 4 ↗
Francisco Partners GP IV Management Ltd10% owner Sale −237.7K $3.53 $839K Aug 19, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding GDRX · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.9M$8.4M0.00%Jun 30, 2026
VANGUARD STRATEGIC EQUITY FUND
VANGUARD HORIZON FUNDS
1.3M$3.6M0.03%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.1M$3.1M0.00%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.0M$2.9M0.00%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
646.9K$1.9M0.00%Jun 30, 2026
Pacer US Small Cap Cash Cows 100 ETF
Pacer Funds Trust
736.7K$1.7M0.05%Apr 30, 2026
U.S. SMALL CAP VALUE PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
559.2K$1.7M0.01%Jul 31, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
483.2K$1.7M0.00%Aug 31, 2026
Schwab U.S. Small-Cap ETF
SCHWAB STRATEGIC TRUST
450.8K$1.6M0.01%Aug 31, 2026
SIIT SMALL/MID CAP FUND
SEI INSTITUTIONAL INVESTMENTS TRUST
396.3K$1.4M0.22%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list GDRX's shares (CUSIP 38246G108), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • LSV ASSET MANAGEMENTSCHEDULE 13G · passive (13G) · 5.9M shares5.5%
    Nov 10, 2026 · ↗
  • Francisco Partners Management, L.P.SCHEDULE 13D/A · activist (13D) · 52.6M shares32.9%
    Aug 26, 2026 · ↗
  • Francisco Partners GP IV Management LimitedSCHEDULE 13D/A · activist (13D) · 52.6M shares32.9%
    Aug 26, 2026 · ↗
  • Francisco Partners GP IV, L.P.SCHEDULE 13D/A · activist (13D) · 52.6M shares32.9%
    Aug 26, 2026 · ↗
  • Francisco Partners IV-A, L.P.SCHEDULE 13D/A · activist (13D) · 17.6M shares11.0%
    Aug 26, 2026 · ↗
  • Francisco Partners IV, L.P.SCHEDULE 13D/A · activist (13D) · 35.0M shares21.9%
    Aug 26, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming goodrx as client
$0$500K$1.0M$1.5M$2.0M2023 Q1: $100K20232025 Q2: $456K2025 Q3: $520K2025 Q4: $510K20252026 Q1: $580K2026 Q2: $610K2026 Q3: $610K2026
  • GOODRX, INC.GOODRX, INC. · 2026 Q3 · CSP, HCR$380K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPGOODRX, INC · 2026 Q3 · HCR, MMM$60K
    Filing ↗
  • CONTINENTAL STRATEGY, LLCGOODRX, INC. · 2026 Q3 · HCR$90K
    Filing ↗
  • S-3 GROUPGOODRX · 2026 Q3 · PHA, HCR$80K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPGOODRX, INC · 2026 Q2 · HCR, MMM$60K
    Filing ↗

Government Contracts

Federal awards to GoodRx Holdings, Inc. · USAspending

No federal contract awards found for GoodRx Holdings, Inc..

U.S. Patents

Recent USPTO applications naming GoodRx Holdings, Inc.

No USPTO patent applications found for GoodRx Holdings, Inc..

Annual Financials

From GDRX's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$796.9M$792.3M$750.3M$766.6M$745.4M
Operating income$87.5M$65.8M-$27.0M$1.7M$13.4M
Net income$30.4M$16.4M-$8.9M-$32.8M-$25.3M
Diluted EPS$0.09$0.04-$0.02-$0.08-$0.06
Operating cash flow$167.9M$183.9M$138.3M$146.8M$178.8M
Cash and equivalents$261.8M$448.3M$672.3M$757.2M$941.1M
Total assets$1.40B$1.39B$1.59B$1.60B$1.61B
Total liabilities$787.8M$663.4M$826.8M$789.8M$775.9M
Shareholders' equity$616.3M$724.7M$762.0M$814.8M$831.7M

As GoodRx Holdings, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in GDRX's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 4.02Non-reliance on financialsNov 2, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeAug 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 6, 2026
    EDGAR ↗

About GoodRx Holdings, Inc.

From SEC EDGAR company records
Industry (SIC 7374)Services-Computer Processing & Data Preparation
SectorTechnology
HeadquartersSANTA MONICA, CA
IncorporatedDE